Explore ALPCO's Diverse Products for Gastroenterology Research
AGA Guidelines: Calprotectin and C-Reactive Protein Monitoring for the Management of Crohn’s Disease
Download ou infograhpic prepared by ALPCO and gain a comprehensive overview of the American Gastroenterological Association (AGA) guidelines, offering a new perspective on managing Crohn's Disease using biomarkers.
Key highlights include the guideline panel's 11 conditional recommendations, particularly focusing on the use of a biomarker- and symptom-based monitoring strategy. It clarifies the significance of fecal calprotectin and CRP levels in assessing disease activity and guiding the need for endoscopic evaluation.
[Infographic] Biomarker Monitoring for the Management of Crohn’s Disease
Important products for Gastroenterology
-
Calprotectin Immunoturbidimetric Assay$0.00The Calprotectin Immunoturbidimetric Assay is an in vitro diagnostic particle-enhanced immunoassay intended for use by trained laboratory personnel for the quantitative measurement of fecal calprotectin, a neutrophilic protein that is a marker of intestinal mucosal inflammation, in human stool.
-
Calprotectin Chemiluminescence ELISA$838.00The ALPCO Calprotectin Chemiluminescence ELISA is an in vitro diagnostic chemiluminescent assay intended for the quantitative measurement of fecal calprotectin, a neutrophilic protein that is a marker of intestinal mucosal inflammation, in human stool.
-
Calprotectin ELISA$692.00Calprotectin ELISA is for the quantitative determination of calprotectin in human stool. Health Canada Licensed , Research Use Only. Not for Use in Diagnostic Procedures.
-
C-Reactive Protein ELISA (CRP ELISA)$341.00The CRP ELISA is intended for the quantitative measurement of C-reactive protein (CRP) in human plasma, serum, stool and urine. For Research Use Only. Not For Use In Diagnostic Procedures. - Results in just over 2 hours - Measure levels of CRP levels in stool and urine - Ready-to-use controls and calibrators
Spotlight: Immunoturbidimetric Assay for Fecal Calprotectin
Extraction to Results – Simplify Complexity
Leverage the power of our FDA-Cleared Immunoturbidimetric (IT) Assay for fecal calprotectin designed to integrate seamlessly with your existing clinical chemistry analyzer. Experience a method that is not only time and cost-efficient but also a viable alternative to conventional and send-out methodologies.
GET YOUR TIME BACK
Upgrading to ALPCO’s Immunoturbidimetric solution for calprotectin testing offers a 40%-65% reduction in time to first result compared to leading Flash Chemiluminescence automated systems.
ACCURACY
ALPCO’s Calprotectin IT Assay combines the clinical sensitivity and specificity clinicians expect with the efficiency and repeatability today’s laboratories require.
MAXIMIZE THROUGHPUT
Increase throughput by more than 57% when comparing tests per hour from a leading CLIA system to ALPCO’s Immunoturbidimetric assay running on a clinical chemistry analyzer.
COST SAVINGS
Realize a savings of up to 87% on the cost per test when comparing the average send-out cost to ALPCO’s in-house cost per test.
Ready to Schedule Your Free Evaluation?
See for yourself why labs are switching to ALPCO’s new FDA-cleared Calprotectin Immunoturbidimetric Assay.
One free kit per laboratory. Void where prohibited.
Simplicity, Efficiency, and Cost Effectiveness, All While Elevating Confidence in Your Results.
FAQs
The calprotectin immunoturbidimetric assay (80-CALPHU-IT200, -100) is 510(k)-cleared in the U.S., IVDD in the EU, and has been submitted for review by Health Canada.
It is recommended to run calibrators once per month and with every kit lot change. Two controls are typically run each day calprotectin testing is performed.
Unlike traditional ELISA, which could have up to 22 non-reportables per run (8 calibrators and 3 controls in duplicate), the immunoturbidimetric assay requires only two non-reportables (2 controls) per day, easily accommodating low volume to high volume testing at a competitive cost per test.
ALPCO Gastroenterology Resources to Advance Your Discoveries
Differentiating IBD from IBS with Fecal Calprotectin Testing
In an effort to improve patient care, an increasing number of gastroenterologists are using fecal calprotectin levels as a first step in the diagnosis of IBD versus IBS.
Diagnostic Testing in GI Health
60 to 70 million Americans are affected by gastrointestinal (GI) diseases and disorders each year. The estimated annual U.S. cost associated with GI disorders is over 140 billion dollars. Gl diseases and disorders can have a significant impact on quality of life, often contributing to anxiety and depression.
ALPCO's Superior Calprotectin Assay: Maximize Efficiency & Accuracy
Automate on Your Current Analyzer Without Sacrificing Clinical Sensitivity or Specificity
Consolidate and Improve Calprotectin Testing on Clinical Chemistry Analyzers with ALPCO
Testing Fecal Calprotectin on a CLIA System? Consolidate Testing with the Calprotectin Immunoturbidimetric Assay.
Boost Profitability with In-House Calprotectin Testing from ALPCO
For laboratories with a compatible clinical chemistry analyzer, on-boarding of the calprotectin immunoturbidimetric assay is simple.
High Throughput Calprotectin Testing with ALPCO Immunoturbidimetric Assay
With clinical sensitivity of 91% and clinical specificity of 93%, the ALPCO calprotectin immunoturbidimetric assay offers the efficiency of automation without sacrificing clinical performance.
Explore all of Gastroenterology resources
Follow ALPCO on Social Media
Stay up to date with new products, articles, and events.